HIF-1α can inhibit the pharmacological effects of dendritic vaccines in a 4T1 breast cancer model, suggesting that hypoxia may inhibit the anti-tumor effects of DCs to act as a tumor-promoting agent [197] (Table 4). This evidence concerns the gene HIF1A and neoplasm.